Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III

Редакционная статья: Открытие малых молекул-лидов: движущая сила в раскрытии новых противораковых мишеней и механизмов, том III
Leilei Fu, Yinu Wang, Y Zhang
2026-05-27

computational biologyhigh-throughput screeningmulti-drug resistancenatural productssmall molecule lead compounds
Discovery of Small Molecule Lead Compounds: a Driving Force to Unravel New Anti-Cancer 14Targets and Mechanisms-Volume III 15 Natural products featuring complex structures and a wide range of biological activities serve as vital 16 sources for the development of novel anticancer agents, particularly due to their capacity to overcome 17 multi-drug resistance. An effective strategy for discovering new anticancer drugs involves seeking lead 18 compounds that target previously unexplored molecular entities, including specific enzymes, receptors, 19 and genes. Advanced approaches such as computational biology and high-throughput screening can 20 further aid in identifying promising drug candidates. This research topic highlights recent advances in 21 this area and comprises eight articles. We had the opportunity to review a broad spectrum of both 22 original research and review articles within the field. In the following, we present a synthesis of the 23 key findings and concepts elaborated in each of the accepted contributions.
1
Advanced approaches such as computational biology and high-throughput screening support identification of promising anticancer drug candidates.
2
Natural products with complex structures and diverse bioactivities are vital sources for developing novel anticancer agents and can help overcome multi-drug resistance.
3
Searching for lead compounds that target previously unexplored molecular entities (enzymes, receptors, genes) is an effective strategy for new anticancer drug discovery.
4
The research topic compiled eight articles (original research and reviews) summarizing recent advances in small-molecule lead discovery for anticancer targets and mechanisms.

Small molecule lead compounds for anticancer drug discovery

Identification and characterization of novel anticancer targets and mechanisms through discovery of small-molecule lead compounds, including natural products, targeting enzymes, receptors, and genes aided by computational biology and high-throughput screening

Publication Details
Publication Date
2026-05-27
Journal
Publisher
ISSN
Cited by
0
Access Type
Author Information
Authors
Leilei Fu
Yinu Wang
Y Zhang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%